Anixa Biosciences
ANIX
$2.94
Share price
-1.01%
Change (1 day)
-26.32%
Change (1 year)
Categories
Anixa Biosciences (ANIX) - P/B ratio
P/B ratio as of May 2024 : 4.01
According to Anixa Biosciences's latest financial reports the company has a price-to-book ratio of 4.01.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Anixa Biosciences - P/B ratio (from 2009 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 5.16 | 11.62% |
| 2022-12-31 | 4.62 | 80.01% |
| 2021-12-31 | 2.57 | -70.95% |
| 2020-12-31 | 8.84 | -36.23% |
| 2019-12-31 | 13.9 | -3.58% |
| 2018-12-31 | 14.4 | 190.56% |
| 2017-12-31 | 4.95 | -89.67% |
| 2016-12-31 | 47.9 | 821.02% |
| 2015-12-31 | 5.20 | -13.78% |
| 2014-12-31 | 6.03 | -150.33% |
| 2013-12-31 | -12.0 | -57.06% |
| 2012-12-31 | -27.9 | -252.28% |
| 2011-12-31 | 18.3 | 160.67% |
| 2010-12-31 | 7.02 | -66.19% |
| 2009-12-31 | 20.8 | |
| 2008-12-31 | N/A | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A | |
| 2003-12-31 | N/A | |
| 2002-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -28.64% | 🇺🇸 USA |